To investigate an effect of smoking cessation on chronic obstructive pulmonary 1 disease (COPD) mortality in Asians. 2 Method. The data was obtained from the Japan Collaborative Cohort Study for Evaluation 3 of Cancer Risk (JACC Study). A total of 41,465 Japanese men and 52,662 Japanese women 4 aged 40-79 years who had no history of COPD, asthma, other chronic lung diseases, 5 cardiovascular disease or cancer were followed between 1988 and 2008. 6 Results. During median 18-year of follow-up, there were 285 (251 men and 34 women) 7
Introduction 19
Chronic obstructive pulmonary disease (COPD) is a long-standing, crippling disease 20 characterized by accelerated decline of lung function. The disease is commonly brought by 21 aging and long-term tobacco smoking (Burrows et al., 1977; Fletcher and Peto, 1977) . The 22 latest report from World Health Organization described that COPD is the only major cause 23 of deaths that has increased in recent years and that it is predicted to become the third 24 leading cause of death worldwide by 2030, both are due to the expansion of smoking habit 25 in developing world and increasing life expectancy (WHO report, 2008) . Recent updated 26 international guidelines define COPD as a preventable and treatable disease by smoking 27 cessation that convincingly palliates the accelerated lung function decline (Rabe et al., 28 2007) . 29 Several prospective studies have described lower COPD mortality risks in former 30 smokers compared to continuous smokers (Carstensen et al., 1987; Doll et al., 1980; Doll et 31 al., 2004; Rogot and Murray, 1980) . However, they were worksite-based studies in male 32 Caucasians (Carstensen et al., 1987; Doll et al., 2004; Rogot and Murray, 1980) , except for 33 one study conducted in women (Doll et al., 1980) . Moreover, no studies have addressed 34 whether there may be certain duration of smoking cessation that would significantly reduce 35 risk of COPD mortality to the level similar to never smokers. The detailed examination of this issue would enable us to formulate more an explicit 37 public health recommendation. Therefore, in this 18-year follow-up cohort study of 38 approximately 95,000 Japanese men and women, we examined risk of COPD mortality 39 associated not only with smoking status but time since quitting smoking. 
Methods

42
The Japan Collaborative Cohort Study for Evaluation of Cancer Risk (JACC study) was 43 initiated 1988 -1990 (Kawado et al., 2005 Ohno and Tamakoshi, 2001 years of smoking cessation. We also excluded 2,736 men and 2,930 women with a reported 50 history of COPD, asthma, other chronic lung diseases, cardiovascular disease or cancer at 51 baseline, leaving 41,465 men and 52,662 women for the present analysis.
52
Mortality surveillance was conducted systematically by reviewing death certificates.
53
The underlying causes of death according to the International Classification of Diseases 54 (ICD-10) were obtained centrally from the Ministry of Health and Welfare. COPD was 55 4 defined as ICD-10 codes of J41 to J44 and J47. The present study was approved by the 56 Ethical Committee, Nagoya University and Osaka University. Sex-specific, age-adjusted and multivariable-adjusted hazard ratios(HRs) and their 95% 64 confidence intervals(95% CIs) were calculated by Cox proportional hazards models. Duration 65 of smoking cessation was divided to three groups (0-4, 5-9 and ≥10 years before the baseline).
66
Variables included in the multivariable-adjusted model were age at baseline, body mass index, 67 ethanol intake, hours of walking, hours of exercise, education, perceived mental stress, and 68 histories of hypertension and diabetes. Number of cigarettes smoked per day and age of 69 smoking initiation were also included in the smoking cessation analysis. for sex-by-smoking status was tested by using cross-product terms of sex with smoking status.
74
In order to evaluate the specificity of association of smoking status or smoking cessation 75 duration with COPD mortality, all-cause mortality was also modeled, and the result was 76 compared with that of COPD. This was done by computing a test statistic:
is the coefficient for all-cause mortality, SE(b 1 ) and SE(b 2 ) are the corresponding standard 79 errors for the association with COPD and all-cause mortality, respectively (Allison, 1995) . 
Results
90
The proportions of current and former smokers were 54% and 25% in men, and 6% and 91 2% in women, respectively. Majority of male smokers (68%) smoked 20 or more cigarettes 92 per day, but the corresponding proportion in female current smokers were 31%. Compared 93 with never or current smokers, former smokers were older, more educated, and more likely to 94 have hypertension and diabetes mellitus in both men and women (Table 1) .
6
A total of 251 deaths from COPD among 41,465 men and 34 deaths among 52,662 96 women were documented during the 18-year follow-up. Both former and current smoking 97 were significantly associated with increased COPD mortality for both men and women in 98 models adjusted for age and potential confounding variables ( Table 2) . The 99 multivariable-adjusted HRs (95% CIs) for former and current smokers compared with never 100 smokers were 2.97 (1.76-5.02) and 4.46 (2.72-7.29) in men and 8.57 (2.75-26.7) and 9.26 101 (4.19-20.5) in women, respectively (Table 2 ). There appeared dose-response associations 102 between the number of cigarettes smoked daily and age-and multivariable-adjusted risk of 103 COPD mortality among current smokers in both sexes. Although crude COPD mortality rates 104 were higher in men than in women in any smoking status categories at baseline, associations 105 of both former and current smoking with COPD mortality tended to be stronger in women 106 than in men (P for sex-by-smoking status interaction =0.08).
107
Compared with current smokers, former smokers at baseline were associated with lower 108 COPD mortality in men but only when cessation duration was five years or more before the 109 baseline (Table 3) . Men who had quit smoking more than 10 years before baseline had COPD 110 mortality risk close to never smokers. Quitters for less than five years did not experience the 111 lowering of mortality risk compared to current continuous smokers. The finding did not 112 change materially even after excluding COPD deaths that occurred within five years from the 113 baseline or individuals who reported persistent phlegm symptom at baseline (HRs: 95% CIs 114 were 1.19 0.80-1.79 and 1.11: 0.71-1.72, respectively). There were too few death cases in 115 7 female former smokers (n=4) at each smoking cessation group to yield meaningful results.
116
The associations of smoking status (P=0.005 in men, P<0.001 in women) and 117 smoking cessation duration (P<0.001 in men) with COPD mortality were stronger than 118 those with all-cause mortality (Supplemental tables 1 and 2). Washington white registers' cohort (Tockman and Comstock, 1989) .
127
Our study also revealed that the duration of smoking cessation was inversely associated 128 with COPD mortality in men, and the excess risk that would have been observed if they had 129 continuous smoking could be reduced after long-term (≥10 years) cessation before the 130 baseline similar to the level observed in never smokers.
131
A few studies have evaluated the duration of quitting smoking associated with COPD 132 mortality and morbidity (Lokke et al., 2006; Rogot and Murray, 1980) . Our finding that 133 accounted for other smoking-related variables, which previous studies did not address, was . That study showed a dose-response relationship between the duration of smoking 136 cessation and cumulative incidence of COPD, and the odds ratio for stage 2 or more COPD in 137 ex-smokers who had quit 25 years or more at the end of follow-up compared to continuous 138 smokers was similar to that in never smokers (Lokke et al., 2006) . Another 16-year 139 observation in the US veterans described that crude COPD mortality rate fell to 140 approximately one fifth of continuous smokers if subjects had quit smoking 20 years or more 141 at the end of follow-up (Rogot and Murray, 1980) .
142
It is noteworthy that both former and current smokers were more strongly associated with 143 COPD mortality in women than in men, especially in female heavy smokers who currently 144 smoked 20 or more cigarettes per day. The interaction for sex-by-smoking status was found to 145 be of borderline significance (P=0.08) in the multivariable model. Similarly, Copenhagen 146 City Heart Study (Lange et al., 1992) and British doctors' cohort study (Doll et al., 1980; Doll 147 et al., 2004) also presented that the COPD mortality ratio associated with smoking in female 148 was higher than that in male, however the number of female deaths from COPD was too 149 small in both studies to confirm the gender difference. The higher age-adjusted relative risks 150 for COPD hospitalization in female smokers compared the risk in male smokers was also 151 observed in Danish longitudinal population study (P=0.08 for the interaction for sex by first-degree relatives, women showed significantly lower lung function than smoking male 164 first-degree relatives ,which implied a genetic predisposition for smoking-induced lung 165 damage in women (Silverman et al., 2000) . In the current study, the misclassification of 166 smoking status as never smoking in women was smaller than that in men, which may 167 contribute to the stronger association between smoking and mortality in women. In addition, 168 the finding might have been observed by chance due to small number of women who died 169 from COPD.
170
Potential effects of smoking cessation on pulmonary pathology have been reported.
171
Macroscopic signs of chronic bronchitis (edema, erythema and mucus) disappeared totally 172 after 6 months' smoking cessation (Skold et al., 1992) . In addition, after smoking cessation, 173 the number of macrophages in bronchoalveolar lavage fluid (Skold et al., 1992) , blood 174 neutrophils and lymphocytes (Jensen et al., 1998) was largely reversed, and those in bronchoalveolar lavage fluid normalized at 6, 9, 15 months, respectively(Skold et al., 1996) . 176 These data indicated that the inflammatory changes are reversible rapidly after smoking 177 cessation. However, in the present study, quitters for less than five years did not experience 178 the lowering of COPD mortality risk compared to current continuous smokers. One possible 179 explanation is that the sample in the present study included people who already had 180 preclinical but irreversible emphysema. Indeed, a recent study in Japan showed that only 181 9.4% of cases with airflow limitation reported a previous diagnosis of COPD (Fukuchi et al., 182 2004) . Even among early stage COPD patient, it takes 11-years or more for sustained quitters 183 to experience the same rate of FEV 1 decline as never smokers (Anthonisen et al., 2002) . 184 We could not clarify the association between the duration of smoking cessation and 185 COPD mortality in women due to the small number of deaths in former smokers. However, 186 one previous intervention study demonstrated that women experienced larger improvements 187 in lung function with smoking cessation than men (▵FEV 1 change: 3.7% vs. 1.6%) (Connett et 188 al., 2003) . The effect of smoking cessation on COPD incidence and mortality in women 189 warrants further investigation.
190
Since persons who quit smoking years prior to the enrollment were more likely to be 191 unhealthy or had some respiratory symptoms, we conducted analyses by excluding the early 192 deaths of COPD within 5-year of follow-up or those who had persistent phlegm at baseline.
193
This exclusion, however, did not alter our results essentially.
194
Some limitations in the present study merit discussion. COPD develops in a long-term 195 11 process and is often undiagnosed (Fukuchi et al., 2004; Mannino et al., 2000) . Therefore, the for men.
204
Our study takes advantages of a long observation period, a large population-based 205 samples and the availability of information about potential confounding factors for COPD. 206 We have found that smoking status and smoking cessation duration were more strongly 207 associated with COPD than with all-cause mortality.
208
Overall, the present study suggests that women may be more susceptible to smoking 209 cigarettes for COPD mortality, and that longer time of smoking cessation was associated with 210 progressively decreased COPD mortality in men. We conclude that smokers should be 211 encouraged to stop smoking as early as possible for the prevention of COPD. hours of walking (<0.5, 0.5, 0.6-0.9, and ≥1.0 hour per day), hours of exercise (<1, 1-2, 3-4, and ≥5 hours per week), education (<10, 10-12, 13-15, and ≥16 years), perceived mental Age-adjusted HR 1.0 -----------------------1.00 (0.31-3.18)-----------------------0.10 (0.05-0.21) * : Information on number of years since quitting smoking was missing for 471 men and for 103 women. 
